Pancreatic beta cell (β-cell)

Pancreatic β-cells are specialized endocrine cells located in the islets of Langerhans in the pancreas; their principal function is the production and regulated secretion of insulin and amylin, maintaining blood glucose homeostasis. Dysfunction or destruction of β-cells leads to abnormal glucose metabolism, primarily manifesting as diabetes mellitus. Therapeutic strategies and drugs often target either the preservation or stimulation of β-cell function rather than directly binding to a single molecular entity[2][3][4][5][7]. Special notes: - "Pancreatic β-cell function" is not a canonical molecular target but rather a cellular physiological process; the true molecular targets for modulating β-cell function include signaling proteins, ion channels (e.g., ATP-sensitive potassium channels), and transcription factors (such as PDX1[1][4]) within the β-cell machinery. - In drug discovery, molecules like "sulfonylurea receptor" (SUR1/ABCC8), "ATP-sensitive potassium channel" (KATP channel/Kir6.2), and "GLP-1 receptor" are considered direct pharmacological targets—not "β-cell function" as such[2][3]. This entry should be flagged as not a canonical target for molecular classification and drug development frameworks.

Other names

Beta cellβ-cellpancreatic islet beta cell

Stimulate insulin secretion by modulating ATP-sensitive K+ channels (sulfonylureas) Amplify endogenous incretin pathway to enhance insulin secretion (GLP-1 agonists, DPP-4 inhibitors)